Literature DB >> 26001662

Prospective progression from high-prevalence disorders to bipolar disorder: Exploring characteristics of pre-illness stages.

Aswin Ratheesh1, Susan M Cotton2, Jennifer K Betts2, Andrew Chanen2, Barnaby Nelson2, Christopher G Davey2, Patrick D McGorry2, Michael Berk3, Andreas Bechdolf4.   

Abstract

BACKGROUND: Identification of risk factors within precursor syndromes, such as depression, anxiety or substance use disorders (SUD), might help to pinpoint high-risk stages where preventive interventions for Bipolar Disorder (BD) could be evaluated.
METHODS: We examined baseline demographic, clinical, quality of life, and temperament measures along with risk clusters among 52 young people seeking help for depression, anxiety or SUDs without psychosis or BD. The risk clusters included Bipolar At-Risk (BAR) and the Bipolarity Index as measures of bipolarity and the Ultra-High Risk assessment for psychosis. The participants were followed up for 12 months to identify conversion to BD. Those who converted and did not convert to BD were compared using Chi-Square and Mann Whitney U tests.
RESULTS: The sample was predominantly female (85%) and a majority had prior treatment (64%). Four participants converted to BD over the 1-year follow up period. Having an alcohol use disorder at baseline (75% vs 8%, χ(2)=14.1, p<0.001) or a family history of SUD (67% vs 12.5%, χ(2)=6.0, p=0.01) were associated with development of BD. The sub-threshold mania subgroup of BAR criteria was also associated with 12-month BD outcomes. The severity of depressive symptoms and cannabis use had high effects sizes of association with BD outcomes, without statistical significance. CONCLUSIONS AND LIMITATIONS: The small number of conversions limited the power of the study to identify associations with risk factors that have previously been reported to predict BD. However, subthreshold affective symptoms and SUDs might predict the onset of BD among help-seeking young people with high-prevalence disorders.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Anxiety; At-risk; Bipolar; Depression; Prospective; Substance

Mesh:

Year:  2015        PMID: 26001662     DOI: 10.1016/j.jad.2015.04.025

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  8 in total

1.  Cannabis and Cannabinoids in Mood and Anxiety Disorders: Impact on Illness Onset and Course, and Assessment of Therapeutic Potential.

Authors:  Sabrina L Botsford; Sharon Yang; Tony P George
Journal:  Am J Addict       Date:  2019-10-02

2.  Assessment of the diagnostic performance of two new tools versus routine screening instruments for bipolar disorder: a meta-analysis.

Authors:  Mehdi Sayyah; Ali Delirrooyfard; Fakher Rahim
Journal:  Braz J Psychiatry       Date:  2022 May-Jun

3.  Bipolar At-Risk Criteria: An Examination of Which Clinical Features Have Optimal Utility for Identifying Youth at Risk of Early Transition From Depression to Bipolar Disorders.

Authors:  Jan Scott; Steven Marwaha; Aswin Ratheesh; Iain Macmillan; Alison R Yung; Richard Morriss; Ian B Hickie; Andreas Bechdolf
Journal:  Schizophr Bull       Date:  2017-07-01       Impact factor: 9.306

Review 4.  Challenges and developments in research of the early stages of bipolar disorder.

Authors:  Elisa Brietzke; Adriane R Rosa; Mariana Pedrini; Mariane N Noto; Flavio Kapczinski; Jan Scott
Journal:  Braz J Psychiatry       Date:  2016-08-11       Impact factor: 2.697

5.  Clinical characteristic of prodromal symptoms between bipolar I and II disorder among Chinese patients: a retrospective study.

Authors:  Qian Zhao; Tong Guo; Yang Li; Lei Zhang; Nan Lyu; Amanda Wilson; Xuequan Zhu; Xiaohong Li
Journal:  BMC Psychiatry       Date:  2021-05-31       Impact factor: 3.630

6.  Is early exposure to cannabis associated with bipolar disorder? Results from a Finnish birth cohort study.

Authors:  Alexander Denissoff; Antti Mustonen; Anni-Emilia Alakokkare; James G Scott; Musa B Sami; Jouko Miettunen; Solja Niemelä
Journal:  Addiction       Date:  2022-04-08       Impact factor: 7.256

Review 7.  Consensus on nomenclature for clinical staging models in bipolar disorder: A narrative review from the International Society for Bipolar Disorders (ISBD) Staging Task Force.

Authors:  Ralph Kupka; Anne Duffy; Jan Scott; Jorge Almeida; Vicent Balanzá-Martínez; Boris Birmaher; David J Bond; Elisa Brietzke; Ines Chendo; Benicio N Frey; Iria Grande; Danella Hafeman; Tomas Hajek; Manon Hillegers; Marcia Kauer-Sant'Anna; Rodrigo B Mansur; Afra van der Markt; Robert Post; Mauricio Tohen; Hailey Tremain; Gustavo Vazquez; Eduard Vieta; Lakshmi N Yatham; Michael Berk; Martin Alda; Flávio Kapczinski
Journal:  Bipolar Disord       Date:  2021-07-23       Impact factor: 5.345

8.  An evolutionary approach to mania studying Sardinian immigrants to Argentina.

Authors:  Mauro G Carta; Alessandra Perra; Michela Atzeni; Silvia D'Oca; Maria F Moro; Peter K Kurotschka; Daniela Moro; Federica Sancassiani; Luigi Minerba; Maria V Brasesco; Gustavo Mausel; Antonio E Nardi; Leonardo Tondo
Journal:  Braz J Psychiatry       Date:  2017-03-09       Impact factor: 2.697

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.